RESULTS

BMD data (a) CONCLUSIONS
 Our data demonstrated that patients with diagnosis of GHD at pubertal period had a lower BMD than pre-pubertal ones. This data probably is a consequence of the mild bone demineralization due to the GHD itself. This data support the necessity to start the rhGH therapy as early as possible to promote an optimal bone growth.  In our study, patients with pathological brain NMR had a lower BMD respect to patients with a normal NMR. This can be the consequence of a more severe phenotype secondary to structural abnormalities of the hypothalamic-pituitary region.
 DEXA might be considered a useful diagnostic tool to complete the diagnosis in GHD patients and to optimally guide therapeutic strategies.
Moreover, DEXA should be repeated at the end of treatment in order to evaluate the effects of rhGH therapy on bone metabolism.
BMD data (b)
 BMD SDS values were significantly lower in pubertal patients respect to pre-pubertal ones (p <0.001) and in patients with pathological brain NMR imaging respect to with normal NMR one (p = 0.03) In all population study, mean BMD SDS was «low for age» according to ISCD, but not pathological (-1.15 ± 0.97)
Correlations
AIMS OF THE STUDY
 To assess the BMD using the dual energy x-ray absorptiometry (DEXA) in a cohort of children with GHD Bone, growth plate and mineral metabolism
